Immune Predictors of Mortality After Ribonucleic Acid Virus Infection
- PMID: 31621854
- PMCID: PMC7107456
- DOI: 10.1093/infdis/jiz531
Immune Predictors of Mortality After Ribonucleic Acid Virus Infection
Abstract
Background: Virus infections result in a range of clinical outcomes for the host, from asymptomatic to severe or even lethal disease. Despite global efforts to prevent and treat virus infections to limit morbidity and mortality, the continued emergence and re-emergence of new outbreaks as well as common infections such as influenza persist as a health threat. Challenges to the prevention of severe disease after virus infection include both a paucity of protective vaccines as well as the early identification of individuals with the highest risk that may require supportive treatment.
Methods: We completed a screen of mice from the Collaborative Cross (CC) that we infected with influenza, severe acute respiratory syndrome-coronavirus, and West Nile virus.
Results: The CC mice exhibited a range of disease manifestations upon infections, and we used this natural variation to identify strains with mortality after infection and strains exhibiting no mortality. We then used comprehensive preinfection immunophenotyping to identify global baseline immune correlates of protection from mortality to virus infection.
Conclusions: These data suggest that immune phenotypes might be leveraged to identify humans at highest risk of adverse clinical outcomes upon infection, who may most benefit from intensive clinical interventions, in addition to providing insight for rational vaccine design.
Keywords: Collaborative Cross; RNA virus infection; immune correlates of mortality.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures



Similar articles
-
Immune Correlates of Protection From West Nile Virus Neuroinvasion and Disease.J Infect Dis. 2019 Mar 15;219(7):1162-1171. doi: 10.1093/infdis/jiy623. J Infect Dis. 2019. PMID: 30371803 Free PMC article.
-
Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.J Virol. 2011 Jan;85(1):217-30. doi: 10.1128/JVI.01805-10. Epub 2010 Oct 27. J Virol. 2011. PMID: 20980507 Free PMC article.
-
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.PLoS One. 2011 Apr 26;6(4):e18995. doi: 10.1371/journal.pone.0018995. PLoS One. 2011. PMID: 21541326 Free PMC article.
-
Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus.Avian Pathol. 2003 Dec;32(6):567-82. doi: 10.1080/03079450310001621198. Avian Pathol. 2003. PMID: 14676007 Free PMC article. Review.
-
Yellow fever vector live-virus vaccines: West Nile virus vaccine development.Trends Mol Med. 2001 Aug;7(8):350-4. doi: 10.1016/s1471-4914(01)02048-2. Trends Mol Med. 2001. PMID: 11516995 Free PMC article. Review.
Cited by
-
Characterization of Collaborative Cross mouse founder strain CAST/EiJ as a novel model for lethal COVID-19.Sci Rep. 2024 Oct 24;14(1):25147. doi: 10.1038/s41598-024-77087-1. Sci Rep. 2024. PMID: 39448712 Free PMC article.
-
Neuroinvasive Flavivirus Pathogenesis Is Restricted by Host Genetic Factors in Collaborative Cross Mice, Independently of Oas1b.J Virol. 2023 Jul 27;97(7):e0071523. doi: 10.1128/jvi.00715-23. Epub 2023 Jun 13. J Virol. 2023. PMID: 37310228 Free PMC article.
-
Peripheral and lung resident memory T cell responses against SARS-CoV-2.Nat Commun. 2021 May 21;12(1):3010. doi: 10.1038/s41467-021-23333-3. Nat Commun. 2021. PMID: 34021148 Free PMC article.
-
A Multitrait Locus Regulates Sarbecovirus Pathogenesis.mBio. 2022 Aug 30;13(4):e0145422. doi: 10.1128/mbio.01454-22. Epub 2022 Jul 12. mBio. 2022. PMID: 35862771 Free PMC article.
-
Forward genetic screen of homeostatic antibody levels in the Collaborative Cross identifies MBD1 as a novel regulator of B cell homeostasis.PLoS Genet. 2022 Dec 27;18(12):e1010548. doi: 10.1371/journal.pgen.1010548. eCollection 2022 Dec. PLoS Genet. 2022. PMID: 36574452 Free PMC article.
References
-
- Churchill GA, Airey DC, Allayee H, et al. ; Complex Trait Consortium The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004; 36:1133–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases